Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
Benefit-Stacking in Bakery: Ardent Mills Targets GLP-1 Demands - Featured image
GLP-1 Impact on Food Industry

Benefit-Stacking in Bakery: Ardent Mills Targets GLP-1 Demands

Dr. Adrian Vale, MD
Reviewed by Dr. Adrian Vale, MDInternal Medicine · Board-Certified Obesity Medicine
·6 min read

On this page

  • The Impact of GLP-1 Medications on Food and Bakery Consumption
  • Ardent Mills' Benefit-Stacking Approach
  • Key Innovations from Ardent Mills' Portfolio
  • Labeling Challenges and Regulatory Considerations
  • Future Outlook for Grain-Based Categories
  • Key Takeaways for Brands and GLP-1 Users
  • What This Means for Metabolic Health and Bakery Innovation
  • Why Nutrient Density Matters for GLP-1 Users
  • UltraGrain 100% Whole Wheat Flour
  • Chickpea Flour and Snacks
  • Additional Formulations and Support

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

GLP-1 medications are reshaping bakery demands, driving growth in high-fiber, high-protein products. Ardent Mills is leading with benefit-stacking strategies using UltraGrain flour and chickpea ingredients to support satiety and digestive health for users. This guide details the research, innovations, and future outlook.

Share

On this page

  • The Impact of GLP-1 Medications on Food and Bakery Consumption
  • Ardent Mills' Benefit-Stacking Approach
  • Key Innovations from Ardent Mills' Portfolio
  • Labeling Challenges and Regulatory Considerations
  • Future Outlook for Grain-Based Categories
  • Key Takeaways for Brands and GLP-1 Users
  • What This Means for Metabolic Health and Bakery Innovation
  • Why Nutrient Density Matters for GLP-1 Users
  • UltraGrain 100% Whole Wheat Flour
  • Chickpea Flour and Snacks
  • Additional Formulations and Support

Benefit-Stacking in Bakery: Ardent Mills Targets GLP-1 Demands

GLP-1 medications like Ozempic and Wegovy are transforming consumer eating habits, boosting demand for high-fiber, high-protein, and low-sugar grain-based bakery products. As adoption grows, companies like Ardent Mills are pioneering benefit-stacking strategies to align bakery innovations with the nutritional priorities of GLP-1 users, who experience reduced "food noise," cravings, and appetite. This comprehensive guide explores how these shifts create both challenges and opportunities in the food and beverage (F&B) landscape.

The Impact of GLP-1 Medications on Food and Bakery Consumption

Rising GLP-1 use is notably influencing food and drink innovation across categories, including bakery, where new product development (NPD) opportunities abound. GLP-1 receptor agonists work by mimicking the GLP-1 hormone, which regulates blood sugar, slows gastric emptying, and signals fullness to the brain. This leads to smaller portions and a preference for nutrient-dense foods that support satiety, muscle maintenance, digestive health, and weight management—key concerns for users managing metabolic health.

Due to reduced appetite, GLP-1 users cut back on snacks and indulgent foods, opting for products with better nutritional profiles. Matt Schueller, director of marketing insights at Ardent Mills, highlights these shifts in bread, bakery, cereal, and snacks. "According to our proprietary research, as many as one in ten adults could be taking a GLP-1. This is projected to reduce total adult caloric intake by 1.5 to 2.1% and, according to KPMG, to drive an estimated US$48 billion in annual reductions in F&B spending through 2034. For grain-based categories, this creates both pressure and opportunity," he tells Food Ingredients First.

Why Nutrient Density Matters for GLP-1 Users

GLP-1 therapies enhance insulin sensitivity and promote gradual weight loss, but users often prioritize foods that prevent muscle loss and sustain energy. High-fiber and protein-rich options help by promoting prolonged fullness and gut health, complementing the medications' effects on metabolic pathways. Ardent Mills' research shows GLP-1 users seek high fiber (78%), high nutrients (78%), low carbohydrates (73%), and high plant protein (61%)—preferences that align with broader wellness trends.

Ardent Mills' Benefit-Stacking Approach

Benefit-stacking involves combining fiber, plant protein, and whole grains in familiar bakery formats to deliver multiple nutritional benefits per serving. This strategy upgrades products for GLP-1-driven needs while preserving taste and texture. "Brands can capture share by reformulating with nutrient-dense ingredients. The shift is about upgrading products through ‘benefit-stacking,’ combining fiber, plant protein, and whole grains to support satiety and digestive health. By adding multiple nutritional benefits to familiar formats, brands can increase value per serving while maintaining the taste and texture consumers expect," Schueller explains.

"We advise our customers to anchor innovation in universal nutritional benefits so they can address GLP-1-driven needs while maintaining mainstream appeal." Importantly, fiber demand extends beyond GLP-1 users—more than 50% of consumers are willing to pay more for high-fiber grain-based foods, supporting long-term category growth.

"Our research indicates that GLP-1 users prioritize satiety, muscle maintenance, digestive health, and weight management support. While motivations may vary by life stage, the formulation implications are consistent: nutrient density per bite matters more than ever."

— Matt Schueller, Ardent Mills

This drives innovation toward ingredients delivering concentrated nutrition without compromising sensory quality. Smaller portions must satisfy, making functional whole grains and pulses ideal for fiber and protein delivery.

Key Innovations from Ardent Mills' Portfolio

UltraGrain 100% Whole Wheat Flour

Ardent Mills' portfolio aligns perfectly with this evolution. "An example is our UltraGrain 100% whole wheat flour, which delivers whole grain nutrition with the taste, texture, and color consumers prefer, enabling fiber-forward reformulations," Schueller says. Used in high-fiber sandwich breads, it maintains softness and preferred texture, ideal for GLP-1 users seeking portion-controlled, nutrient-dense options.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play

Chickpea Flour and Snacks

Chickpeas are gaining traction for "better-for-you" products, especially with GLP-1 demand. Their gluten-free profile, fiber content, and nutty flavor appeal to weight-loss consumers craving indulgence without guilt. "Another example is our work with chickpeas and chickpea flour, which offer a good source of fiber and a gluten-free alternative, highly versatile ingredient profile. GLP-1 users are contributing to incremental demand, particularly in snack applications, where satiety and nutrient density matter," Schueller notes.

"By incorporating chickpea-based solutions alongside whole grains, brands can develop nutrient-dense products that align with evolving dietary patterns while maintaining flavor and functionality." Examples include snack crackers, crisps, and whole grain tortillas optimized for nutrient density and portion control.

Additional Formulations and Support

Ardent Mills has developed meal-replacement snack formats, prioritized by 61% of GLP-1 users, and bakery products balancing fiber and protein. "The key is balance. Fiber and protein inclusion must be calibrated to avoid density or dryness. Our technical teams help brands optimize hydration, structure, and sensory performance," Schueller adds.

For GLP-1 users tracking their metabolic health, apps like Shotlee can help monitor intake of these high-fiber, protein-rich foods alongside medication effects, ensuring balanced nutrition.

Labeling Challenges and Regulatory Considerations

Communicating "GLP-1-friendly" positioning is tricky without regulatory approval. No official permission exists for "GLP-1" or "GLP-1-friendly" claims on products referencing the medication's benefits, as this could imply drug-like effects. In the US, FDA approval is required; in the EU, EFSA authorization.

Brands can use approved claims like "high in protein," "high in fiber," or "low in sugar" to signal appeal. As GLP-1 adoption grows, pressure for regulatory changes may mount, but caution is advised.

Future Outlook for Grain-Based Categories

The GLP-1 movement is reshaping bakery by curbing indulgent products but opening high-value segments. "GLP-1 medications will continue to shape the grain, flour, and pulse categories in the years ahead," Schueller notes. "The food industry is at a crossroads. As GLP-1 adoption expands, we expect sustained pressure on low-fiber, high-sugar formulations and accelerated demand for nutrient-dense, functional ingredients. Whole grains and pulses will likely gain share as brands seek naturally fiber-rich and protein-forward solutions."

"Grains are not losing relevance—they are evolving to meet new expectations. Ardent Mills is positioned to help customers move food forward by combining grain science, consumer insight, and scalable ingredient solutions. The brands that innovate strategically now will be the best positioned to capture this next phase of growth."

Key Takeaways for Brands and GLP-1 Users

  • Consumer Priorities: High fiber (78%), nutrients (78%), low carbs (73%), plant protein (61%) drive reformulation.
  • Benefit-Stacking Wins: Combine whole grains, pulses for satiety and health support without sensory trade-offs.
  • Innovation Examples: UltraGrain breads, chickpea snacks, nutrient-dense tortillas.
  • Market Impact: 1 in 10 adults on GLP-1; $48B F&B spend reduction by 2034.
  • For Patients: Discuss high-fiber bakery options with your doctor to complement GLP-1 therapy; track progress with tools like Shotlee for symptoms and nutrition.

What This Means for Metabolic Health and Bakery Innovation

Ardent Mills exemplifies how the bakery sector can thrive amid GLP-1 shifts by prioritizing nutrient density. For those on GLP-1 medications managing metabolic health, these products offer practical ways to sustain muscle mass and digestive wellness. Brands innovating now will lead in a market valuing quality over quantity. Stay informed on related topics like GLP-1 side effects management and peptide therapy nutrition guides.

Source Information

Originally published by foodingredientsfirst.com.Read the original article →

Read next

Keep exploring

Same topic: GLP-1 Medications

All GLP-1 Medications articles →
Beyond the Scale: Tracking GLP-1 Success with Advanced Health Monitoring
Health Technology

Beyond the Scale: Tracking GLP-1 Success with Advanced Health Monitoring

GLP-1 medications like Ozempic and Wegovy are transforming weight management, but understanding your body's response is key. Learn how innovative health monitors can help you track progress and manage side effects effectively.

7 min read
GLP-1 Weight Loss Drugs: Impact on Food Industry & Your Diet
Health & Wellness

GLP-1 Weight Loss Drugs: Impact on Food Industry & Your Diet

New market data suggests a unique opportunity for protein-focused brands as GLP-1 therapies alter consumer eating habits. Learn how this shift affects your health strategy.

7 min read
Beyond 'Ozempic Teeth': Understanding and Managing 'Ozempic Breath'
Health & Wellness

Beyond 'Ozempic Teeth': Understanding and Managing 'Ozempic Breath'

The rise of GLP-1 medications like Ozempic and Mounjaro has brought about new conversations around their side effects, including the emerging concern of 'Ozempic breath.' This article delves into the causes, implications, and effective management strategies for this common issue.

7 min read

More in GLP-1 Impact on Food Industry

Ozempic Price Cut: Generic Semaglutide Arrives in Canadian Pharmacies
Health & Wellness

Ozempic Price Cut: Generic Semaglutide Arrives in Canadian Pharmacies

Two generic versions of Ozempic have arrived in Canadian pharmacies, offering diabetes and weight loss patients significant cost savings compared to the brand-name medication.

7 min read
Retatrutide Breaks Records: What Phase 3 TRIUMPH-1 Data Means
Health & Wellness

Retatrutide Breaks Records: What Phase 3 TRIUMPH-1 Data Means

Eli Lilly's Retatrutide has shown remarkable weight loss potential in Phase 3 trials. We break down the TRIUMPH-1 results, safety data, and what patients can expect.

9 min read
Driving on Ozempic & Mounjaro: Avoiding the £1,000 DVLA Fine
Health & Wellness

Driving on Ozempic & Mounjaro: Avoiding the £1,000 DVLA Fine

New regulations warn that GLP-1 medication users could face significant fines if side effects impair driving. Here is the complete guide to staying safe and compliant.

8 min read
Share this article
  1. Home
  2. Blog
  3. Benefit-Stacking in Bakery: Ardent Mills Targets GLP-1 Demands
Dr. Adrian Vale, MD — Internal Medicine · Board-Certified Obesity Medicine
Medically reviewed

Dr. Adrian Vale, MD

Internal Medicine · Board-Certified Obesity Medicine

Dr. Adrian Vale is a board-certified internal medicine physician with a clinical focus on obesity medicine and metabolic health. He reviews Shotlee guides and articles on GLP-1 medications, peptide therapy, and weight-management protocols for clinical accuracy.

View all articles reviewed by Dr. Adrian Vale, MD
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community